[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Publications found: 1,835
Sort by:
Cancer Anorexia-Cachexia Syndrome Disease - Global Clinical Trials Review, H2, 2020 US$ 2,500.00

Cancer Anorexia-Cachexia Syndrome Disease - Global Clinical Trials Review, H2, 2020 SUMMARY GlobalData's clinical trial report, “Cancer Anorexia-Cachexia Syndrome Disease - Global Clinical Trials Revi...

November 2020 104 pages
Uveal Melanoma Disease - Global Clinical Trials Review, H2, 2020 US$ 2,500.00

Uveal Melanoma Disease - Global Clinical Trials Review, H2, 2020 SUMMARY GlobalData's clinical trial report, “Uveal Melanoma Disease - Global Clinical Trials Review, H2, 2020' provides an overview of...

November 2020 158 pages
Global Cancer Vaccine Partnering Terms and Agreements 2010-2020 US$ 3,495.00

... Case studies of real-life Cancer Vaccine deals Access to Cancer Vaccine contract documents Leading Cancer Vaccine deals by value since 2014 Most active Cancer Vaccine dealmakers since 2014 In Global Cancer Vaccine Partnering 2014-2019: Deal trends, players, financials and ...

November 2020 250 pages
Global Oncology Partnering 2015-2020: Deal trends, players and financials US$ 3,495.00

... , Vomiting, Chemotherapy, Radiotherapy, Adenocarcinoma, Basal cell carcinoma, Bile duct cancer, Bladder cancer, Bone cancer, Brain cancer, Breast cancer, Cervical cancer, Colorectal cancer, Endometrial, Esophageal cancer, Gastric cancer, Head and neck cancer, Kaposi's sarcoma, Kidney cancer, Leukemia, Acute ...

November 2020 2600 pages
Global Cancer Diagnostics Partnering Terms and Agreements 2014-2020 US$ 3,495.00

... Case studies of real-life Cancer Diagnostics deals Access to Cancer Diagnostics contract documents Leading Cancer Diagnostics deals by value since 2014 Most active Cancer Diagnostics dealmakers since 2014 In Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players, financials and ...

November 2020 500 pages
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2014-2020 US$ 3,495.00

... cancer monoclonal antibody deals by value since 2014 In Cancer Monoclonal Antibody Partnering Terms & Agreements, the available deals are listed by: Company A-Z Headline value Stage of development at signing Deal component type Specific oncology ...

November 2020 350 pages
Global Cancer Immunotherapy Market Analysis & Forecast to 2025: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT) & IDO Inhibitors US$ 4,900.00

Within the cancer therapeutics space, which today is worth over $160 billion globally, immunotherapeutic drugs have gained worldwide acceptance. This is because they are targeted therapeutics that hav...

November 2020 450 pages
Global Prostate Cancer Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024) US$ 1,200.00

of the Report The report entitled “Global Prostate Cancer Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)”, provides a detailed analysis of the global prostate cancer market with...

November 2020 124 pages
Gastric and Gastroesophageal Junction Adenocarcinoma - Global Drug Forecast and Market Analysis to 2029 US$ 10,995.00

Gastric and Gastroesophageal Junction Adenocarcinoma - Global Drug Forecast and Market Analysis to 2029 SUMMARY Gastric and gastroesophageal junction adenocarcinoma (G/GEJAC) is the fifth most common...

October 2020 147 pages
Thymoma (Thymic Epithelial Tumor) Disease - Global Clinical Trials Review, H2 2020 US$ 2,500.00

Thymoma (Thymic Epithelial Tumor) Disease - Global Clinical Trials Review, H2 2020 SUMMARY GlobalData's clinical trial report, “Thymoma (Thymic Epithelial Tumor) Disease - Global Clinical Trials Revie...

October 2020 162 pages
India Oncology NGS Market Size, Share & Trends Analysis Report By Technology, By Application, By Product & Service, By Workflow, By End-use, And Segment Forecasts, 2020 - 2027 US$ 5,950.00

This report can be delivered to the clients within 72 Business Hours India Oncology NGS Market Growth & Trends The India oncology NGS market size is expected to reach USD 70.59 million by 2027, acco...

October 2020 133 pages
Hemato Oncology Testing Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Services), By Cancer Type (Leukemia, Lymphoma, MPNs), By Technology, By End-use, By Region, And Segment Forecasts, 2020 - 2027 US$ 5,950.00

This report can be delivered to the clients within 72 Business Hours Hemato Oncology Testing Market Growth & Trends The global hemato oncology testing market size is expected to reach USD 7.2 billio...

October 2020 142 pages
Global Breast Cancer Therapeutics Market Size study, By Product (Hormone Drugs, Chemotherapy Drugs, Targeted Drug Therapy), By Distribution Channel (Hospitals, Ambulatory Surgical Centers, Clinics, e-commerce, Retail Pharmacies), and Regional Forecasts 2020-2027 US$ 3,950.00

Global Breast Cancer Therapeutics Market is valued approximately at USD 19.57 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 10.16% over the forecast period 2020-20...

October 2020 200 pages
Global Prostate Cancer Therapeutics Market Size study, By Therapy (Hormone Therapy, Targeted Therapy, Chemotherapy, and Biologic Therapy) and By Distribution Channel (Hospital Pharmacies, Online Sales, Retail Pharmacies, and Others), and Regional Forecasts 2020-2027 US$ 3,950.00

Global Prostate Cancer Therapeutics Market is valued approximately at USD 9.9 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.68% over the forecast period 2020-202...

October 2020 200 pages
Astrocytoma Disease - Global Clinical Trials Review, H2, 2020 US$ 2,500.00

Astrocytoma Disease - Global Clinical Trials Review, H2, 2020 SUMMARY GlobalData's clinical trial report, “Astrocytoma Disease - Global Clinical Trials Review, H2, 2020' provides an overview of Astroc...

October 2020 1227 pages
Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4]), By Application (Lung, Melanoma, Leukemia, Lymphoma) - Global Forecast to 2024 US$ 3,000.00

... to launch new and most effective therapies. According to the report “Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4]), By Application ...

October 2020 195 pages
Global Prostate Cancer Market (by Cancer Type, Drug, Therapy & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024) US$ 1,800.00

The global prostate cancer market is anticipated to reach US$14.41 billion in 2024, witnessing growth at a CAGR of 4.62%, over the period 2020-2024. Factors such as increasing geriatric population, ri...

September 2020 147 pages
Oncology Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Cancer Type, By Region, And Segment Forecasts, 2020 - 2027 US$ 5,950.00

This report can be delivered to the clients within 72 Business Hours Oncology Clinical Trials Market Growth & Trends The global oncology clinical trials market size is expected to reach USD 16.6 bil...

September 2020 120 pages
Global Thyroid Cancer Diagnostic Market Size study, by Type (Papillary carcinoma, Follicular carcinoma, Others), by Technique (Blood test, Imaging, Biopsy, Others), by End-Use (Hospital laboratories, Cancer diagnostic centers, Research institutes) and Regional Forecasts 2020-2027 US$ 4,950.00

Global Thyroid Cancer Diagnostic Market is valued approximately at USD 2.4 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.5% over the forecast period 2020-2027. T...

September 2020 200 pages
Oncology Companion Diagnostic Market Size, Share & Trends Analysis Report By Product & Service, By Technology (IHC, NGS), By Disease Type (Breast Cancer, Leukemia), By End-use, By Region, And Segment Forecasts, 2020 - 2027 US$ 5,950.00

This report can be delivered to the clients within 48 Business Hours Oncology Companion Diagnostic Market Growth & Trends The global oncology companion diagnostic market size is expected to reach US...

September 2020 183 pages
Global Immuno-Oncology Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024) US$ 900.00

of the Report The report titled “Global Immuno-Oncology Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)”, provides an in-depth analysis of the global immuno-oncology market by va...

September 2020 82 pages
Asia Pacific Radiation Oncology Market Size, Share & Trends Analysis Report By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), By Technology, By Application, And Segment Forecasts, 2020 - 2027 US$ 5,950.00

This report can be delivered to the clients within 72 Business Hours Asia Pacific Radiation Oncology Market Growth & Trends The Asia Pacific radiation oncology market size is expected to reach USD 2...

August 2020 124 pages
Breast Cancer Brachytherapy Market Size, Share & Trends Analysis Report By Technology (High Dose Rate, Low Dose Rate), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2020 - 2027 US$ 5,950.00

This report can be delivered to the clients within 72 Business Hours Breast Cancer Brachytherapy Market Growth & Trends The global breast cancer brachytherapy market size is estimated to reach USD 1...

August 2020 120 pages
U.S. Radiation Oncology Market Size, Share & Trends Analysis Report By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), By Technology, By Application, And Segment Forecasts, 2020 - 2027 US$ 5,950.00

This report can be delivered to the clients within 24 Business Hours The U.S. Radiation Oncology Market Growth & Trends The U.S. radiation oncology market size is expected to reach USD 3.9 billion b...

August 2020 109 pages
Next Generation Cancer Diagnostics: Technologies and Global Markets US$ 5,500.00

Report : The scope of this report includes next generation diagnostic technologies, applications, industry subsegments, major funding initiatives, patents and companies. The market sizes for next gene...

August 2020 318 pages
Global Next-Generation Breast Cancer Diagnostic and Screening Market: Focus on Products, Technologies, Cancer Sub-Type, End Users, Country Data (14 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030 US$ 4,750.00

Market Report Coverage - Next Generation Breast Cancer Diagnostic and Screening Market SegmentationProduct Type - BRCA tests, ER/PR tests, HER2 testsTechnology- Real-Time Polymerase Chain Reaction (RT...

August 2020 206 pages
Cancer Diagnostics Companies in China US$ 1,800.00

This study focuses on China’s Cancer Diagnostics industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...

July 2020 53 pages
Cancer Diagnostics Industry Forecasts - China Focus US$ 1,800.00

This study focuses on China’s Cancer Diagnostics industry forecasts. In the two past decades, the ... -term forecasts through 2023 and 2028 are presented. The primary and secondary research is done in China in ... reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...

July 2020 103 pages
Cancer Diagnostics Markets in China US$ 4,000.00

China's demand for Cancer Diagnostics has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...

July 2020 213 pages
Cancer/Tumor Profiling Market by (Technology (Immunoassay, NGS, PCR, In-Situ Hybridization, Microarray), Cancer Type (Breast, Lung, Colorectal, Prostate, Melanoma)), Biomarker Type (Genomic, Protein), Application, Region - Global Forecast to 2025 US$ 4,950.00

... various cancer/tumor profiling technologies and their adoption pattern. It aims at estimating the market size and future growth potential of cancer/tumor profiling market and the different segments such as by technology, cancer ...

July 2020 293 pages
Artificial Intelligence (AI) in Cancer US$ 3,950.00

REPORT INCLUDES: to cancer, most common types, and main medical issuesA look at the major applications of AI tools in the diagnosis, therapy, R&D and health management of cancerInformation on types...

July 2020 38 pages
Cancer Vaccines Market by Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, and Viral Vector & DNA Cancer Vaccines), Type (Preventive Cancer Vaccines and Therapeutic Cancer Vaccines), Indication (Cervical Cancer, Prostate Cancer, and Others), and End User (Pediatrics and Adults): Global Opportunity Analysis and Industry Forecast, 2020–2027 US$ 5,769.00

... cancer vaccines market is segmented based on technology, indication, type end use, and region. Based on technology, it is categorized into dendritic cells (DC) cancer vaccines, recombinant cancer vaccines, antigen/adjuvant cancer vaccines, whole cell cancer vaccines ...

July 2020 284 pages
Japan Cancer Drug Market, Dosage, Price & Clinical Trials Insight 2025 US$ 3,000.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. 'Japan Cancer Drug Market, Dosage, Price & Clinical Trials Insight 2025' Report Highlight...

July 2020 1200 pages
Cancer Vaccines Market, Pipeline Analysis Report 2020 US$ 1,113.00

“Global Cancer Vaccines market size is expected to surpass US$ 8.5 Billion by 2025” Report :Detailed Insights of the to Cancer Vaccines and Mechanism of Cancer VaccinesThe Market Size of the Global Ca...

June 2020 115 pages
Thyroid Cancer Diagnostics Market Size, Share & Trends Analysis Report By Technique (Blood Test, Imaging, Biopsy), By Type (Papillary Carcinoma, Follicular Carcinoma), By End Use, By Region, And Segment Forecasts, 2020 - 2027 US$ 5,950.00

Thyroid Cancer Diagnostics Market Growth & Trends The global thyroid cancer diagnostics market size is expected to reach USD 3.6 billion by 2027, expanding at a CAGR of 5.5%, according to a new report...

June 2020 100 pages
Cancer Diagnostics Global Market - Forecast to 2026 US$ 4,950.00

The understanding of the pathways of cancer development and their causes has led to the development of novel methodologies, and there is an emerging trend towards precision health in today’s world to...

June 2020 405 pages
2024 Global Cancer Diagnostics Market: USA, Europe, Japan-Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Emerging Technologies, Latest Instrumentation, Growth Opportunities US$ 27,500.00

... business opportunities emerging in the global cancer diagnostics market during the next five ... market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country. Estimated universe of laboratories performing cancer diagnostic testing by country. Cancer ...

June 2020 1200 pages
2024 US Cancer Diagnostics Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Emerging Technologies, Latest Instrumentation, Growth Opportunities US$ 4,850.00

... . Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers. Estimated universe of laboratories performing cancer diagnostic testing. Cancer statistics ...

June 2020 620 pages
2024 Argentina Cancer Diagnostics Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Emerging Technologies, Latest Instrumentation, Growth Opportunities US$ 3,500.00

... cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market ... the disease. During the next five years, the cancer diagnostics market is promising to be an exciting, dynamic and ...

June 2020 535 pages
2024 Asia-Pacific Cancer Diagnostics Market: A 17-Country Analysis-Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Emerging Technologies, Latest Instrumentation, Growth Opportunities US$ 14,500.00

... specific opportunities and growth strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field ...

June 2020 935 pages
2024 Australia Cancer Diagnostics Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Emerging Technologies, Latest Instrumentation, Growth Opportunities US$ 3,500.00

... cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market ... the disease. During the next five years, the cancer diagnostics market is promising to be an exciting, dynamic and ...

June 2020 535 pages
2024 Austria Cancer Diagnostics Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Emerging Technologies, Latest Instrumentation, Growth Opportunities US$ 3,500.00

... cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market ... the disease. During the next five years, the cancer diagnostics market is promising to be an exciting, dynamic and ...

June 2020 535 pages
2024 Bahrain Cancer Diagnostics Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Emerging Technologies, Latest Instrumentation, Growth Opportunities US$ 3,500.00

... cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market ... the disease. During the next five years, the cancer diagnostics market is promising to be an exciting, dynamic and ...

June 2020 535 pages
2024 Bangladesh Cancer Diagnostics Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Emerging Technologies, Latest Instrumentation, Growth Opportunities US$ 3,500.00

... cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market ... the disease. During the next five years, the cancer diagnostics market is promising to be an exciting, dynamic and ...

June 2020 535 pages
2024 Belgium Cancer Diagnostics Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Emerging Technologies, Latest Instrumentation, Growth Opportunities US$ 3,500.00

... cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market ... the disease. During the next five years, the cancer diagnostics market is promising to be an exciting, dynamic and ...

June 2020 535 pages
2024 Brazil Cancer Diagnostics Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Emerging Technologies, Latest Instrumentation, Growth Opportunities US$ 3,500.00

... cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market ... the disease. During the next five years, the cancer diagnostics market is promising to be an exciting, dynamic and ...

June 2020 535 pages

Filters

Search

Publishers

4
1
3
2
3
5
1
6
9
10
2
4
10
18
5
97
8
3
100
7
1
8
119
3
1
1
6
12
2
10
1
11
18
18
8
1
4
12
1
5
11
2
43
3
6
2
1,004
5
25
2
52
16
10
6
19
12
5
1
10
17
2
30
4
8

Regions

25
11
4
4
4
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
25
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
18
25
7
6
71
54
53
53
52
51
52
97
910

Price

Date

Pages

Offers

1
1